Migraine: developing drugs for acute treatment
- Series Title(s):
- Guidance for industry
United States. Department of Health and Human Services, issuing body.
United States. Food and Drug Administration, issuing body.
Center for Drug Evaluation and Research (U.S.), issuing body.
- Silver Spring, MD : Center for Drug Evaluation and Research, February 2018
- Clinical Trials as Topic Drug Evaluation -- standards Migraine Disorders -- drug therapy Acute Disease Adult Child Research Design Humans United States United States. Department of Health and Human Services. United States. Food and Drug Administration.
- Guideline Technical Report
- The National Library of Medicine believes this item to be in the public domain. (More information)
- 1 online resource (1 PDF file (9 pages)).
- NLM Unique ID:
- 101734065 (See catalog record)